Abivax (AAVXF) Short term Debt (2021 - 2025)
Abivax has reported Short term Debt over the past 5 years, most recently at $1.5 million for Q4 2025.
- Quarterly results put Short term Debt at $1.5 million for Q4 2025, down 96.84% from a year ago — trailing twelve months through Dec 2025 was $1.5 million (down 96.84% YoY), and the annual figure for FY2025 was $1.5 million, down 96.98%.
- Short term Debt for Q4 2025 was $1.5 million at Abivax, down from $48.0 million in the prior quarter.
- Over the last five years, Short term Debt for AAVXF hit a ceiling of $48.0 million in Q4 2024 and a floor of $1.5 million in Q4 2025.
- Median Short term Debt over the past 5 years was $13.0 million (2021), compared with a mean of $20.1 million.
- Biggest five-year swings in Short term Debt: surged 1171.82% in 2024 and later crashed 96.84% in 2025.
- Abivax's Short term Debt stood at $13.0 million in 2021, then soared by 163.78% to $34.2 million in 2022, then tumbled by 88.97% to $3.8 million in 2023, then surged by 1171.82% to $48.0 million in 2024, then crashed by 96.84% to $1.5 million in 2025.
- The last three reported values for Short term Debt were $1.5 million (Q4 2025), $48.0 million (Q4 2024), and $3.8 million (Q4 2023) per Business Quant data.